| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
MyFirstApp Sweden AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.02 |
| 52 Week High | SEK 4.20 |
| 52 Week Low | SEK 1.05 |
| Beta | 1.52 |
| 11 Month Change | 7.16% |
| 3 Month Change | 19.17% |
| 1 Year Change | -49.50% |
| 33 Year Change | -97.80% |
| 5 Year Change | -99.48% |
| Change since IPO | -99.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| EVOL | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 1.0% | -1.7% | -0.6% |
| 1Y | -49.5% | 1.3% | 17.0% |
Return vs Industry: EVOL underperformed the Swedish Medical Equipment industry which returned 1.3% over the past year.
Return vs Market: EVOL underperformed the Swedish Market which returned 17% over the past year.
Price Volatility
| EVOL volatility | |
|---|---|
| EVOL Average Weekly Movement | 21.6% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: EVOL's share price has been volatile over the past 3 months.
Volatility Over Time: EVOL's weekly volatility has decreased from 31% to 22% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1 | Jesper Nord | www.myfirstappsweden.com |
MyFirstApp Sweden AB (publ), an IT company, provides a range of digital services in Sweden. It offers digital applications adapted for children. The company was formerly known as ObsteCare AB (publ) and changed its name to MyFirstApp Sweden AB (publ) in January 2023.
MyFirstApp Sweden AB (publ) Fundamentals Summary
| EVOL fundamental statistics | |
|---|---|
| Market cap | SEK 8.91m |
| Earnings (TTM) | -SEK 5.49m |
| Revenue (TTM) | SEK 2.43m |
3.7x
P/S Ratio-1.6x
P/E RatioIs EVOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVOL income statement (TTM) | |
|---|---|
| Revenue | SEK 2.43m |
| Cost of Revenue | SEK 3.36m |
| Gross Profit | -SEK 930.11k |
| Other Expenses | SEK 4.56m |
| Earnings | -SEK 5.49m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 22, 2024
| Earnings per share (EPS) | -1.24 |
| Gross Margin | -38.34% |
| Net Profit Margin | -226.12% |
| Debt/Equity Ratio | 25.5% |
How did EVOL perform over the long term?
See historical performance and comparison